BRIEF published on 10/20/2025 at 13:33, 1 month 15 days ago Arrive AI Joins Russell 2000 and Russell 3000 Indexes Market Capitalization Institutional Investment Russell Indexes Arrive AI Last Mile Delivery
PRESS RELEASE published on 10/20/2025 at 13:28, 1 month 15 days ago Arrive AI Achieves Listing on the Russell 2000 and Russell 3000 Indexes Arrive AI joins Russell 2000® and Russell 3000® Indexes enhancing visibility and credibility. The inclusion validates disruptive last mile delivery strategy with smart mailboxes and MaaS platform Smart Mailboxes Russell 2000 Russell 3000 Arrive AI Last Mile Delivery
BRIEF published on 10/15/2025 at 13:33, 1 month 20 days ago Arrive AI to Discuss AI Innovations at Maxim Growth Summit Artificial Intelligence Autonomous Delivery Arrive AI Maxim Growth Summit SaaS Impact
PRESS RELEASE published on 10/15/2025 at 13:28, 1 month 20 days ago Arrive AI to Share AI-Powered Growth Story and Meet with Investors at Maxim Growth Summit Arrive AI's CEO Dan O'Toole to participate in Maxim Group 2025 Growth Summit to discuss AI and SaaS impact. Arrive AI redefines logistics with AI-powered delivery network AI Logistics CEO Maxim Group Arrive AI
Published on 12/05/2025 at 02:35, 3 hours 48 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 23 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 18 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 23 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 53 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 32 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 58 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 8 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 23 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 38 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 39 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 22 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
